Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
| DLL3 immunophenotype of LCNEC. Representative cases with positive (A ...
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell ...
DLL3 (delta-like protein 3) expression correlates with stromal ...
International real-world study of DLL3 expression in patients with ...
Exploring the expression of DLL3 in gastroenteropancreatic ...
Impact of DLL3 Expression as Prognostic Factor in Extensive Stage of ...
Representative images of DLL3 protein in small-cell lung cancer (x400 ...
(PDF) International real-world study of DLL3 expression in patients ...
DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and ...
DLL3 – A Breakthrough Target for Small Cell Lung Cancer Therapy-DIMA ...
DLL3 regulates Notch signaling in small cell lung cancer: iScience
Near infrared photoimmunotherapy targeting DLL3 for small cell lung ...
DLL3 Is a Prognostic and Potentially Predictive Biomarker for ...
Assessment of DLL3 and CD3 Expression in Pediatric Tumor FFPE Samples ...
DLL3 regulates the migration and invasion of small cell lung cancer by ...
Immunohistochemistry of DLL3. The cutoff value was set at 1% for DLL3 ...
DLL3 expression is a predictive marker of sensitivity to adjuvant ...
Investigational DLL3 & T-Cell Engager Technology for SCLC | DLL3 ...
a NEN tissue immunostained for DLL3 and RB1 with matching hematoxylin ...
Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in ...
DLL3 expression in normal and tumor tissue. DLL3 protein expression via ...
DLL3 as an Emerging Target for the Treatment of Neuroendocrine ...
(PDF) Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell ...
DLL3 expression in normally functioning livers. (a) The relative ...
DLL3 Targeting in Small Cell Lung Cancer | BioRender Science Templates
JCI - IL-18–secreting CAR T cells targeting DLL3 are highly effective ...
(PDF) Near infrared photoimmunotherapy targeting DLL3 for small cell ...
OncoWuXi Express: Efficacy of DLL3 CAR-T in SHP-77 Tumor Models - WuXi ...
Targeting DLL3 in Small Cell Lung Cancer and Other Neuroendocrine ...
ASCL1 and DLL3 expressions and their clinicopathological implications ...
A case of NEC with diffuse and strong DLL3 positivity. The majority ...
DLL3 positively regulated P53 signaling pathway. | Download Scientific ...
Biological and immunological significance of DLL3 expression in ...
Delta‐like ligand 3: A promising target against small cell lung cancer ...
The morphological features of delta‐like 3 (DLL3) expression in GI‐NEC ...
The pattern of delta‐like 3 (DLL3) and chromogranin A (CHGA) expression ...
Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary ...
Delta-like protein 3 expression and therapeutic targeting in ...
Characterization of DLL3-positive circulating tumor cells (CTCs) in ...
Frontiers | Advances in DLL3-targeted therapies for small cell lung ...
ASCO GU 2026: Efficacy and Safety of the DLL3/CD3 T-Cell Engager ...
(PDF) DLL3: An emerging target in small cell lung cancer
ProsTIC/PCF Global Webinar 2023: DLL3: A New Target for Radioligand ...
The expression levels of delta‐like 3 (DLL3) in... | Download ...
Taking a Bite Out of Small Cell Lung Cancer By Leveraging Precision ...
Emerging therapies targeting the delta-like ligand 3 (DLL3) in small ...
DLL3: Emerging Target in Tumor Therapy Treatment Strategies | KACTUS
Advances in DLL3-targeted therapies for small cell lung cancer ...
ESMO 2024: DLL-3 Targeted Therapy for Neuroendocrine Prostate Cancer
Promising Activity in DLL3-Positive SCLC and NECs with a Novel ...
(PDF) Emerging therapies targeting the delta-like ligand 3 (DLL3) in ...
Influence of preanalytical variables on performance of delta-like ...
Expression of delta-like protein 3 is reproducibly present in a subset ...
Slide 9
DLL3/CD3 T-cell engager | InOncology – Boehringer Ingelheim
Prevalence of Delta-like protein 3 expression in patients with small ...
A Bispecific DLL3/CD3 IgG-Like T-Cell Engaging Antibody Induces ...
Obrixtamig Could Broaden the Reach of DLL3/CD3-Targeted BiTEs in Small ...
Characteristics of DLL3-positive and DLL3-negative pulmonary LCNEC ...
ASCO GU 2024: Interim Results from a Phase 1/2 Study of HPN328, a Tri ...
DLL3: The Next Breakthrough in Small Cell Lung Cancer
【最强组合】肺癌治疗热门靶点——DLL3 & Notch - 自主发布 - 生物在线 Lab-on-Web
Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade ...
Phase 1 trial of DLL3/CD3 IgG-Like T-Cell Engager BI 764532 in Patients ...
Small cell transformation in EGFR-mutated non-small cell lung cancer ...
Full article: Phase I trial of the DLL3/CD3 bispecific T-cell engager ...
Frontiers | Delta-Like Protein 3 Expression in Paired Chemonaive and ...
Targeting DLL3: Innovative Strategies for Tumor Treatment
Combined DLL3-targeted bispecific antibody with PD-1 inhibition is ...
Phase I trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in ...
Relationship between the expressions of DLL3, ASC1, TTF-1 and Ki-67 ...
Ascl1 and Neurog2 Form Novel Complexes and Regulate Delta-like3 (Dll3 ...
Small-cell lung cancer: insights and new treatment options centering ...
DLL3：下一个ADC的明星靶点？
Drug - ETN029: A DLL3-Targeted Peptide Theranostic for Solid Tumors ...
First Report of Response to Tarlatamab in a Patient With DLL3-Positive ...
International Journal of Oncology
Delta-like ligand 3 expression and functional imaging in ...
